Bristol-Myers to cut another 100 jobs; German court invalidates patent on AZ's Seroquel XR;

@FiercePharma: $AZN's Seroquel franchise takes another hit: German court rules XR patent invalid. U.K. did already. Anyone else? More | Follow @FiercePharma

> Bristol-Myers Squibb ($BMY) plans to cut another 100 or so jobs in sales and support functions, soon after disclosing plans to slash 480 from its New Jersey payroll. Report

> AstraZeneca's ($AZN) Seroquel XR, the long-acting version of its newly off-patent antipsychotic drug, saw its patent invalidated in Germany, where it brought in $82 million so far this year. Report

> A group of experts arguing for a global treaty to stop counterfeit drugs was barred from an upcoming WHO meeting. Report

> Cardiologists are weighing the cost of heart disease treatments as prices for drugs and devices set records and insurers ratchet back reimbursements. Report

> Sagent Pharmaceuticals ($SGNT) launched a generic version of the injectable edema and glaucoma treatment Diamox. Report

Medical Device News

 @FierceMedDev: Medtronic gains expanded approval for ts Valiant Captivia stent graft system. More | Follow @FierceMedDev

 @MarkHFierce: Malaysia looking to beef up its medical device clinical testing capabilities. Item | Follow @MarkHFierce

 @DamianFierce: Mindray Medical is recalling anesthesia devices over a leak risk. News | Follow @DamianFierce

> FDA blocks Hospira from importing pumps. Article

> Edwards crushes Medtronic in appeals fight over heart valve patent. Story

Biotech News

 @FierceBiotech: Protein biomarker predicts Type 2 diabetes years in advance. Story | Follow @FierceBiotech

 @JohnCFierce: Want to sell expensive cancer drugs in China? Get the middle class to buy health insurance. Via BMBG. Story | Follow @JohnCFierce

 @RyanMFierce: HepC pill race report 2012: $GILD, $ABT, $VRTX, others rush toward pharma gold. Report | Follow @RyanMFierce

> Pharma groups advance 221 new diabetes drugs as epidemic worsens. Article

> Bayer gambling $4B R&D budget on Xarelto, top blockbuster hopefuls. Story

Biomarkers News

> Biomarker tags AstraZeneca's clot buster activity in patient subgroup. Story

> Genetic mutations signpost inherited heart risk. Item

> Protein marker tags activity for GlaxoSmithKline drug in mesothelioma. More

> Fox Foundation funds BioFIND Parkinson's marker project. News

Drug Delivery News

> Injectable sponge stars and hearts deliver drugs. Story

> Optinose $2.1M grant to deliver autism treatment from the nose to the brain. Item

> Bacterial 'minicells' deliver cancer drugs straight to the target. More

> GSK, XenoPort terminate extended-release gabapentin deal. Article

And Finally... Greece's malaria outbreak has been exacerbated by the country's crippled public health system. Report (sub. req.)

Suggested Articles

AMAG's female libido drug Vyleesi has just won FDA approval. But will it reach blockbuster state? Management and analysts have different opinions.

Roche’s Genentech new innovation targets cancer cells via video game to raise awareness of personalized medicine, tumor types and biomarker testing.

Alexion is undergoing a major makeover by moving away from ultra-rare diseases, but it still has more to pursue in an effort to back up Soliris.